VIL1 and cervical adenocarcinoma: Further logistic regression analysis identified combination of miR-192-5p/HNF1A-AS1/VIL1 panel and TCT tests to achieve greater AUC (0.964) than the TCT test or miR-192-5p/HNF1A-AS1/VIL1 panel detection (Fig. 4D, Table S4), suggesting a potential biomarker for cervical adenocarcinoma.